Trials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.
Wearables have great potential to continue advancing research in Rett syndrome as well as other rare disease areas.
Shiri Diskin, PhD, Head of Medical Writing at Bioforum, sits down with Daphna Laifenfeld, PhD, Chief Scientific Officer at Ibex Medical Analytics to discuss the challenges associated with developing a CER and how to effectively navigate them while creating opportunities that increase efficiencies.
Centralized medical imaging providers must challenge their current processes to improve patient diversity.
The potential of PBPK modeling in answering key questions around these drugs.
Webinar Date/Time: Thu, Mar 2, 2023 1:00 PM EST
Employing a Multi-faceted Approach to Cultivate Inclusivity and Close Disparity.
A use case by Memorial Sloan Kettering Cancer Center explores the potential of EHR-to-EDC.
Advances in technology open door for improved EHR to EDC transfer process.
Regulatory compliance, collaboration, and effective use of technology among ways CROs can overcome challenges.
Tufts CSDD survey finds fostering healthy relationships with site staff is key to a positive outlook.
*** Thursday, March 11, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET *** How can CROs continue to grow in today’s increasingly competitive market? Learn how you can turn client experience into your competitive advantage. *** On demand available after final airing until Mar. 11, 2022 ***
This article sets out a vision of adopting convenient alternative blood sampling approaches that places the needs of the patient at the center and enables active monitoring, before the onset of clinical events, leading to improved healthcare.
eTMF-blockchain technology offers a myriad of application benefits to data quality and integrity while ensuring compliance to ethical standards.
A more user-centered design can allow increased flexibility in the development of eCOA platforms, driving better engagement and participation.
Implementing centralized risk-based monitoring can help meet strict GCP requirements for study conduct, oversight, and recording.
Insights from Bayer’s study review process showcases importance of incorporating feedback from a wider audience of stakeholders.
Identifying KPIs, benchmarks, key data points, and an actionable plan are all keys to accelerating study start-up cycles.
New protocols, remote patient monitoring, and improved standards of care among ways industry can take next steps in CAR T-cell research.
Key takeaways from a survey of 250 oncology patients measuring COVID-19’s impact on patient willingness to participate in clinical trials.
Keys to ensuring your clinical trials better reflect your target population.
Laboratory services organization focuses on easing patient and site burden with improved collection device.
Trials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.
As drug development costs continue to escalate, sponsors are incentivized to find less expensive approaches to develop their assets. FSP models provide increased operational and resourcing flexibility and different pricing plans in comparison to traditional full-service CRO offerings.
Natural language processing models are able to automate the extraction of pertinent information from a vast array of scientific literature.
Automating process can reduce time and resources lost from using manual steps and allows stakeholders to maintain compliance.